Global payments technology company Mastercard (NYSE:MA) will be announcing earnings results this Thursday before market hours. Here’s what to expect.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Amazon reported its Q2 earnings after the bell on Thursday.
Amazon will report its second quarter earnings after the bell on Thursday.
General Dynamics has managed to avoid much of the defense stock pain that came after fighting began in Iran. Wall Street was looking for earnings per share of $3.96 from sales of $13.5 billion. Operating profit margin was 10.4%, up 0.4 percentage point year-over-year.
Coal mining company Peabody Energy (NYSE:BTU) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 12.7% year on year to $1.00 billion. Its GAAP loss of $0.74 per share was 75.9% below analysts’ consensus estimates.

Apple will report its third quarter earnings on Thursday.
P&G posted flat organic sales growth in its fiscal fourth quarter as consumers shifted to cheaper alternatives
Investing.com -- Procter & Gamble Co. (NYSE: PG) reported its fourth-quarter results before the open on Wednesday, slightly beating earnings expectations but missing on revenue.
Sofi stock fell despite topping Q2 earnings and revenue estimates. The fintech raised its full-year 2026 revenue outlook.
Ford Motor (F) shares rose early Wednesday after the automaker lifted its full-year core profit outl
Amazon is expected to report year-over-year AWS revenue growth of 31%-33%, but I think it could be even higher.
HudBay Minerals (HBM) delivered earnings and revenue surprises of -6.67% and -2.75%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Generac Holdings (GNRC) delivered earnings and revenue surprises of +49.23% and -0.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Biogen (BIIB) delivered earnings and revenue surprises of +18.42% and +9.40%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
The fintech's membership surged 35% to 15.8 million and total loan originations hit a record $14.8 billion in the second quarter
Better-than-expected sales helped Biogen regain the support of investors, while AstraZeneca and GSK worked to convince Wall Street that they can hit ambitious revenue targets.
Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 7.5% year on year to $5.44 billion. On the other hand, next quarter’s revenue guidance of $5.27 billion was less impressive, coming in 2.2% below analysts’ estimates. Its non-GAAP profit of $0.86 per share was 3.8% above analysts’ consensus estimates.
Vertiv (VRT) delivered earnings and revenue surprises of +6.29% and -3.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
KeyBanc expects Reddit’s investments in community engagement and advertising monetization to create a durable business capable of generating annual revenue growth above 30%.
United Microelectronics (NYSE:UMC) reported higher second-quarter revenue, wafer shipments and utilization as demand strengthened in communications and consumer applications, while the company raised its 2026 capital-expenditure budget to support silicon photonics and advanced-packaging growth initi
Ford Motor Company (NYSE:F) shares climbed more than 4% after the automaker reported better-than-expected second-quarter results and raised its financial outlook for the full year, supported by stronger operating performance across its core business. The company posted adjusted earnings per share of $0.
Investing.com -- Shares in Vertiv tumbled more than 9% in premarket trading Wednesday even as the data center equipment maker reported second-quarter earnings above estimates and raised its full-year guidance, with a revenue shortfall offseting the beat.
Musk's comments point to a hidden long-term advantage for the memory chip maker.
KLA Corporation (NASDAQ:KLAC) reported stronger-than-expected fiscal fourth-quarter results, but its shares fell more than 10% in pre-market trading on Wednesday after investors focused on a cautious near-term outlook and guidance that offered only limited upside. The semiconductor equipment manufacturer posted earnings per share of $1.
Biogen’s growth portfolio, which includes one closely watched Alzheimer’s drug, is a bright spot in the second quarter.
There’s never a good time to miss on earnings, but memory-chip giant SK Hynix really picked its moment.
In recent days, Bristol Myers Squibb has been in focus as analysts updated earnings forecasts and a biotech partner sought approval for its first commercial product to be used alongside BMS’s cancer drug Opdivo. At the same time, commentators have highlighted Bristol Myers Squibb’s role as a dividend-oriented value name with a pipeline viewed as important for offsetting future patent expirations and evolving product sales trends. Building on this, we’ll explore how higher earnings...